COMMUNITY HEALTHCARE TRUST I (CHCT) Fundamental Analysis & Valuation

NYSE:CHCTUS20369C1062

Current stock price

16.15 USD
-0.01 (-0.06%)
At close:
16.15 USD
0 (0%)
After Hours:

This CHCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CHCT Profitability Analysis

1.1 Basic Checks

  • In the past year CHCT was profitable.
  • In the past year CHCT had a positive cash flow from operations.
  • CHCT had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CHCT had a positive operating cash flow.
CHCT Yearly Net Income VS EBIT VS OCF VS FCFCHCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • CHCT has a Return On Assets (0.21%) which is comparable to the rest of the industry.
  • CHCT's Return On Equity of 0.48% is in line compared to the rest of the industry. CHCT outperforms 43.09% of its industry peers.
  • CHCT's Return On Invested Capital of 2.35% is in line compared to the rest of the industry. CHCT outperforms 43.90% of its industry peers.
  • CHCT had an Average Return On Invested Capital over the past 3 years of 2.34%. This is in line with the industry average of 3.11%.
  • The 3 year average ROIC (2.34%) for CHCT is below the current ROIC(2.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.21%
ROE 0.48%
ROIC 2.35%
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
CHCT Yearly ROA, ROE, ROICCHCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3 4

1.3 Margins

  • CHCT has a Profit Margin (1.72%) which is comparable to the rest of the industry.
  • CHCT's Profit Margin has declined in the last couple of years.
  • CHCT has a Operating Margin (23.88%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of CHCT has declined.
  • CHCT has a Gross Margin of 80.51%. This is amongst the best in the industry. CHCT outperforms 81.30% of its industry peers.
  • CHCT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.88%
PM (TTM) 1.72%
GM 80.51%
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
CHCT Yearly Profit, Operating, Gross MarginsCHCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1

2. CHCT Health Analysis

2.1 Basic Checks

  • CHCT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CHCT has more shares outstanding
  • CHCT has more shares outstanding than it did 5 years ago.
  • CHCT has a worse debt/assets ratio than last year.
CHCT Yearly Shares OutstandingCHCT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CHCT Yearly Total Debt VS Total AssetsCHCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • CHCT has an Altman-Z score of 0.83. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CHCT (0.83) is better than 67.48% of its industry peers.
  • A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
  • The Debt to Equity ratio of CHCT (1.25) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.36
WACC6.62%
CHCT Yearly LT Debt VS Equity VS FCFCHCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.47, CHCT is doing worse than 76.42% of the companies in the same industry.
  • A Quick Ratio of 0.18 indicates that CHCT may have some problems paying its short term obligations.
  • CHCT has a Quick ratio of 0.18. This is amonst the worse of the industry: CHCT underperforms 91.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.18
CHCT Yearly Current Assets VS Current LiabilitesCHCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

6

3. CHCT Growth Analysis

3.1 Past

  • CHCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.43%, which is quite impressive.
  • The earnings per share for CHCT have been decreasing by -14.76% on average. This is quite bad
  • CHCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.49%.
  • Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 9.88% on average per year.
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%

3.2 Future

  • CHCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.29% yearly.
  • CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.55% yearly.
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y10.55%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8

2

4. CHCT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 44.86, the valuation of CHCT can be described as expensive.
  • CHCT's Price/Earnings ratio is in line with the industry average.
  • CHCT is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • CHCT is valuated quite expensively with a Price/Forward Earnings ratio of 33.69.
  • CHCT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 73.17% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CHCT to the average of the S&P500 Index (23.84), we can say CHCT is valued slightly more expensively.
Industry RankSector Rank
PE 44.86
Fwd PE 33.69
CHCT Price Earnings VS Forward Price EarningsCHCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CHCT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 60.98% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.71
CHCT Per share dataCHCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • CHCT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CHCT's earnings are expected to grow with 29.29% in the coming years.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y29.29%
EPS Next 3YN/A

7

5. CHCT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 11.73%, CHCT is a good candidate for dividend investing.
  • CHCT's Dividend Yield is rather good when compared to the industry average which is at 7.24. CHCT pays more dividend than 96.75% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CHCT pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.73%

5.2 History

  • The dividend of CHCT has a limited annual growth rate of 2.43%.
  • CHCT has paid a dividend for at least 10 years, which is a reliable track record.
  • CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.43%
Div Incr Years9
Div Non Decr Years9
CHCT Yearly Dividends per shareCHCT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 2580.24% of the earnings are spent on dividend by CHCT. This is not a sustainable payout ratio.
  • The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP2580.24%
EPS Next 2Y29.29%
EPS Next 3YN/A
CHCT Yearly Income VS Free CF VS DividendCHCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M
CHCT Dividend Payout.CHCT Dividend Payout, showing the Payout Ratio.CHCT Dividend Payout.PayoutRetained Earnings

CHCT Fundamentals: All Metrics, Ratios and Statistics

COMMUNITY HEALTHCARE TRUST I

NYSE:CHCT (3/13/2026, 8:15:48 PM)

After market: 16.15 0 (0%)

16.15

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners79.27%
Inst Owner Change-5.72%
Ins Owners6.13%
Ins Owner Change2.5%
Market Cap461.41M
Revenue(TTM)121.19M
Net Income(TTM)2.08M
Analysts80
Price Target19.13 (18.45%)
Short Float %2.24%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 11.73%
Yearly Dividend1.89
Dividend Growth(5Y)2.43%
DP2580.24%
Div Incr Years9
Div Non Decr Years9
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)163.48%
Min EPS beat(2)-63.24%
Max EPS beat(2)390.2%
EPS beat(4)1
Avg EPS beat(4)45.11%
Min EPS beat(4)-88.54%
Max EPS beat(4)390.2%
EPS beat(8)1
Avg EPS beat(8)-4.32%
EPS beat(12)2
Avg EPS beat(12)-25.93%
EPS beat(16)2
Avg EPS beat(16)-23.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-3.35%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.25%
Revenue beat(12)1
Avg Revenue beat(12)-2.86%
Revenue beat(16)1
Avg Revenue beat(16)-2.66%
PT rev (1m)2.74%
PT rev (3m)5.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 44.86
Fwd PE 33.69
P/S 3.81
P/FCF N/A
P/OCF 8.18
P/B 1.07
P/tB 1.08
EV/EBITDA 13.71
EPS(TTM)0.36
EY2.23%
EPS(NY)0.48
Fwd EY2.97%
FCF(TTM)-1
FCFYN/A
OCF(TTM)1.98
OCFY12.23%
SpS4.24
BVpS15.03
TBVpS14.98
PEG (NY)1.35
PEG (5Y)N/A
Graham Number11.03
Profitability
Industry RankSector Rank
ROA 0.21%
ROE 0.48%
ROCE 2.98%
ROIC 2.35%
ROICexc 2.36%
ROICexgc 2.39%
OM 23.88%
PM (TTM) 1.72%
GM 80.51%
FCFM N/A
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
ROICexc(3y)2.35%
ROICexc(5y)2.74%
ROICexgc(3y)2.4%
ROICexgc(5y)2.8%
ROCE(3y)2.96%
ROCE(5y)3.45%
ROICexgc growth 3Y-9.81%
ROICexgc growth 5Y-6.84%
ROICexc growth 3Y-9.27%
ROICexc growth 5Y-6.96%
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 7.39
Cap/Depr 195.51%
Cap/Sales 70.24%
Interest Coverage 1.12
Cash Conversion 77.86%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.18
Altman-Z 0.83
F-Score5
WACC6.62%
ROIC/WACC0.36
Cap/Depr(3y)239.76%
Cap/Depr(5y)272.78%
Cap/Sales(3y)86.16%
Cap/Sales(5y)94.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y10.55%
EBIT growth 1Y-27.37%
EBIT growth 3Y-5.11%
EBIT growth 5Y0.72%
EBIT Next Year263.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.16%
OCF growth 3Y-2.18%
OCF growth 5Y3.13%

COMMUNITY HEALTHCARE TRUST I / CHCT Fundamental Analysis FAQ

What is the fundamental rating for CHCT stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHCT.


What is the valuation status for CHCT stock?

ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.


What is the profitability of CHCT stock?

COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CHCT stock?

The Price/Earnings (PE) ratio for COMMUNITY HEALTHCARE TRUST I (CHCT) is 44.86 and the Price/Book (PB) ratio is 1.07.


Can you provide the financial health for CHCT stock?

The financial health rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 1 / 10.